The Nigeria Centre for Disease Control (NCDC) reported 576 new infections of COVID-19 Saturday.
In a Twitter update via its verified handle, the government agency said there are now 89,163 confirmed cases of the disease caused by the novel coronavirus in Nigeria.
A total number of 74,789 people it said, have so far been discharged from hospital, while the number of deaths so far is 1,302.
As of Saturday, more than 84.2 million cases of COVID-19 had been reported worldwide with more than 47.4 million cases considered recovered or resolved, according to Johns Hopkins University’s tracking tool. The global death toll stood at more than 1.8 million.
According to a CBC report, Chad has locked down its capital N’djamena for the first time since the outbreak of the pandemic and has declared a dusk to dawn curfew due to a rise in infections.
The UK, the report further stated, has registered a record 57,725 daily coronavirus cases as hospitals in Britain have started receiving batches of the coronavirus vaccine developed by Oxford University and AstraZeneca, which was approved by British regulators this week.
South Korea is extending stringent distancing rules for two more weeks as authorities seek to suppress a viral resurgence, while confirming its first case of an apparently more contagious coronavirus variant detected in South Africa.
Funeral homes in Southern California are turning away bereaved families because they’re running out of space for the bodies. Los Angeles County has surpassed 10,000 COVID-19 deaths.
Meanwhile, India has approved COVID-19 vaccines, paving way for massive immunisation campaign.
India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday, as it prepares to roll out an inoculation programme to stem the coronavirus pandemic.
The trial included data entry into an online platform for monitoring vaccine delivery, along with testing of cold storage and transportation arrangements for the vaccine, the health ministry said in a statement.
The massive exercise was followed by India’s drug regulator recommending the emergency-use approval of two vaccines for COVID-19 — one developed by Oxford University and U.K.-based drugmaker AstraZeneca, and another by the Indian manufacturer Bharat Biotech. Both the vaccines will now have to wait for final approval from the Indian regulator.